Page 19/59 of GNBT 10-Q Employee Compensation a
Post# of 36537
(Total Views: 375)
Posted On: 01/02/2021 4:52:50 PM
Page 19/59 of GNBT 10-Q
Employee Compensation and Settlement Agreements
During the three months ended October 31, 2020, the Company awarded executives and employees bonus compensation of $7,005,416 to be paid in approximately $1 million in cash and $6 million in stock. The cash portion is to be paid out before December 31, 2020, and the stock portion is expected to be issued by January 31, 2021.
Results of Operations
Three months ended October 31, 2020, compared to three months ended October 31, 2019
General and administrative expenses in the three months ended October 31, 2020, and 2019 were $13,008,172 and $4,787,039, respectively. The increase of $8,221,133 is primarily due to bonus compensation of $7,005,416 to be paid in approximately $1 million in cash and $6 million in stock, $500,000 in consulting fees, and approximately $423,000 increase in stock compensation related to the issuance of stock options to employees and consultants.
Source:
https://www.sec.gov/Archives/edgar/data/10597...orm10q.htm
Employee Compensation and Settlement Agreements
During the three months ended October 31, 2020, the Company awarded executives and employees bonus compensation of $7,005,416 to be paid in approximately $1 million in cash and $6 million in stock. The cash portion is to be paid out before December 31, 2020, and the stock portion is expected to be issued by January 31, 2021.
Results of Operations
Three months ended October 31, 2020, compared to three months ended October 31, 2019
General and administrative expenses in the three months ended October 31, 2020, and 2019 were $13,008,172 and $4,787,039, respectively. The increase of $8,221,133 is primarily due to bonus compensation of $7,005,416 to be paid in approximately $1 million in cash and $6 million in stock, $500,000 in consulting fees, and approximately $423,000 increase in stock compensation related to the issuance of stock options to employees and consultants.
Source:
https://www.sec.gov/Archives/edgar/data/10597...orm10q.htm
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼